Anebulo Pharmaceuticals, Inc. (ANEB): Price and Financial Metrics
ANEB Price/Volume Stats
| Current price | $1.59 | 52-week high | $3.30 |
| Prev. close | $1.62 | 52-week low | $0.80 |
| Day low | $1.59 | Volume | 4,200 |
| Day high | $1.69 | Avg. volume | 17,191 |
| 50-day MA | $1.51 | Dividend yield | N/A |
| 200-day MA | $2.09 | Market Cap | 41.23M |
ANEB Stock Price Chart Interactive Chart >
Anebulo Pharmaceuticals, Inc. (ANEB) Company Bio
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients suffering from cannabinoid overdose and addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
ANEB Price Returns
| 1-mo | 60.61% |
| 3-mo | -15.87% |
| 6-mo | -27.73% |
| 1-year | -33.75% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -5.36% |
| 2024 | -30.58% |
| 2023 | -0.15% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...